Schedule 13G ownership disclosure
Beta Bionics Inc
Common Stock · CUSIP: 08659B102
Event date: 2025-01-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Eventide Asset Management, LLC
Shares: 4,857,041.00 · Class: 11.32%
- Finny Kuruvilla, M.D., Ph. D.
Shares: 4,857,041.00 · Class: 11.32%
- Robin C. John
Shares: 4,857,041.00 · Class: 11.32%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001580642-25-000834
- Form type
- SCHEDULE 13G
- Filer
- Beta Bionics, Inc.
- CIK
- CIK 1674632
- Filed
- Feb 05, 2025
- Reporting period
- Jan 31, 2025
- Description
- Schedule 13G beneficial ownership